Cover Image

A CASE OF ACUTE IRON POISONING IN AN ADULT PRESENTING AS FULMINANT HEPATIC FAILURE

SRIDHAR .

Abstract


Abstract :

      Fulminant hepatic failure (or acute liver failure) is defined as the rapid development of hepatocellular dysfunction,    specifically coagulopathy and mental status changes (encephalopathy) in a patient without known prior liver     disease 1 Acute liver failure is a medical emergency          associated with a high mortality rate because of the         development of   cerebral edema, infectious complications, and multiorgan failure. Despite advances in medical         management, mortality rates in patients with acute liver failure remain high in the absence of emergency liver                 transplantation. The predominant cause of acute liver failure differs markedly throughout the world. In the United States and other western countries,  medications, including       acetaminophen and idiosyncratic drug toxicity are the most commonly identified causes of acute liver failure. In France, Japan, and India, severe acute HBV     infection is a leading cause of acute liver failure. 2 This clinical report  summarizes the management of acute fulminant hepatic failure due to acute iron toxicity secondary to suicidal ingestion of ferrous sulphate tablets.

 

Keyword :Acute iron poisoning, acute iron poisoning in an adult, Deferoxamine, acute fulminant failure

 


Full Text:

PDF

References


Hoofnagle JH, Carithers Jr RL, Shapiro C, et al: Fulminant hepatic failure: Summary of a workshop. Hepatology 1995; 21:240-52.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease 9th edition; chapter 93; page 1557

Riordan SM, Williams R: Mechanisms of hepatocyte injury, multi-organ failure, and prognostic criteria in acute liver failure. Sem Liv Dis 2003; 23:203-15.

Weiss B, Alkon E, Weindlar F, et al: Toddler deaths resulting from ingestion of iron supplements ,Los Angeles, 1992-1993. MMWR Morb Mortal Wkly Rep 1993;42:111-113.

Reissman KR, Coleman TJ: Acute intestinal iron intoxication. II: Metabolic, respiratory and circulatory effects of absorbed iron salts. Blood 1955;10:46-51.

Robotham JL, Troxler RF, Lietman PS: Iron poisoning: Another energy crisis. Lancet 1974;2:664-665.

Flomenbaum, Neal E.; Goldfrank, Lewis R.; Hoffman, Robert S.; Howland, Mary Ann; Lewin, Neal A.; Nelson, Lewis S: Goldfrank's Toxicologic Emergencies, 8th Edition; chapter40

Gleason WA, de Mello DE, de Castro FJ, et al: Acute hepatic failure in severe iron poisoning. J Pediatr 1979;95:138-140.

Tenenbein M, Littman C, Stimpson RE: Gastrointestinal pathology in adult iron overdose. J Toxicol Clin Toxicol 1990;28:311-320.

Westlin WF: Deferoxamine as a chelating agent. Clin Toxicol 1971;4:597-602

Anderson AC: Iron poisoning in children. Current Opin Pediatr 1991; 6: 289-294.

Gervitz NR, Wasserman LR: The measurement of iron and iron-binding capacity in plasma containing deferoxamine. J Pediatr 1966;68:802-804.

Helfer RE, Rodgerson DO: The effect of deferoxamine on the determination of serum iron and iron-binding capacity. J Pediatr 1966;68:804-806.

Staple TW, McAlister WH: Roentgenographic visualization of iron preparations in the gastrointestinal tract. Radiology 1964;83:1051-1056.

Longo; Fauci; Kasper; Hauser; Jameson; Loscalzo: Harrison’s principles of internal medicine 18th edition; chapter 205

Mills KC, Curry SC: Acute iron poisoning. Emerg Med Clin North Am 1994;12:397-413.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University